Cardio-Renal Syndrome: Latest Developments in Device-Based Therapy
Author Information
Author(s): Meche Vlad, Kundnani Nilima Rajpal, Sharma Abhinav, Căpăstraru Flavia-Maria, Nistor Daciana, Sarau Cristian Andrei, Gaita Laura
Primary Institution: Victor Babes University of Medicine and Pharmacy, Timisoara, Romania
Hypothesis
This study aimed to evaluate the efficacy and safety of various device-based therapies in managing cardio-renal syndrome (CRS).
Conclusion
Device-based therapies offer a valuable addition to the CRS treatment paradigm, particularly in cases unresponsive to conventional diuretics and other pharmacologic measures.
Supporting Evidence
- Device-based therapies demonstrated varying levels of efficacy in CRS, with significant improvements observed in specific parameters.
- Notable results were a reduction in central venous pressure and improved diuretic responsiveness in acute CRS cases.
- Other relevant endpoints were fewer heart failure hospitalizations and a reduction in renal adverse events.
Takeaway
This study looks at new devices that help treat heart and kidney problems together, especially when regular medicines don't work.
Methodology
A comprehensive analysis of clinical trial data and observational studies involving device-based therapies in patients with CRS was conducted, focusing on hemodynamic endpoints, renal and cardiac function, symptom relief, and adverse events.
Limitations
Some devices presented challenges, including procedure-related complications and a learning curve for optimal device implantation.
Statistical Information
P-Value
p<0.01
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website